"Clonazepam Orally Disintegrating Tablets, USP (C-IV)" on November 18th, due to "potential product carton strength ...

This past July, we reported on the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective ...

French company looks to rein in how it gives discounts in federal program designed to help hospitals that serve low-income ...

Sanofi (SNY) is planning changes to its 340B plan on how it gives discounts to certain hospitals, planning to require institutions to provide ...

Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled ...